Eli Lilly and Novo Nordisk have announced they are working on new oral drugs that can be used for type-2 diabetes and weight ...
Dr. Kaustubh Mahamine, Dr. Ruchir Rastogi, Dr. B. Srihari, and Dr. Chandra Prakash Thakur — will share expert perspectives on the evolving management of Coronary Artery Disease in diabetic patients.
New research suggests that drugs like Ozempic and Wegovy might trigger more than just a slimmer waistline. Many users have ...
A. Diabetes is a chronic illness that develops from a combination of genetics, diet and lifestyle. Too much sugar in the ...
Medicare announced 15 lower drugs after a second round of negotiations with pharmaceutical companies. The drugs include ...
Novo Nordisk's highly anticipated but ultimately unsuccessful Alzheimer's trials were a long shot for the maker of ...
The analysis examined GLP-1 drug use following 382,277 pregnancies in Denmark from the beginning of 2018 through June 2024.
Background Non-adherence to antidiabetic medication remains a major barrier to achieve optimal health outcomes among individuals with diabetes, particularly in developing countries. This issue ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback